Cite
[The disinvestment of benzodiazepines: what aspects contributed to the decision to discontinue reimbursement?]
MLA
Rotteveel, Adriënne H., et al. “[The Disinvestment of Benzodiazepines: What Aspects Contributed to the Decision to Discontinue Reimbursement?].” Nederlands Tijdschrift Voor Geneeskunde, vol. 165, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=34854650&authtype=sso&custid=ns315887.
APA
Rotteveel, A. H., Lambooij, M. S., & de Wit, G. A. (2021). [The disinvestment of benzodiazepines: what aspects contributed to the decision to discontinue reimbursement?]. Nederlands Tijdschrift Voor Geneeskunde, 165.
Chicago
Rotteveel, Adriënne H, Mattijs S Lambooij, and G Ardine de Wit. 2021. “[The Disinvestment of Benzodiazepines: What Aspects Contributed to the Decision to Discontinue Reimbursement?].” Nederlands Tijdschrift Voor Geneeskunde 165 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=34854650&authtype=sso&custid=ns315887.